US stock · Healthcare sector · Drug Manufacturers—General
Company Logo

Biogen Inc.

BIIBNASDAQ

305.15

USD
+1.70
(+0.56%)
Market Closed
22.13P/E
19Forward P/E
1.10P/E to S&P500
43.942BMarket CAP
- -Div Yield
Google Trends
Recent Reddit Comments

New high list today is basically insurance companies (MET HUM AFL CI ), big pharma (AMGN GILD VRTX BIIB) and McDonalds, Pepsi and TMobile. Basically the new high list is AMerica.

1
Reply
Share
Report
Save
Follow

$BIIB is powerful

1
Reply
Share
Report
Save
Follow

BIIB $285 this week

1
Reply
Share
Report
Save
Follow

BIIB about to skyrocket

1
Reply
Share
Report
Save
Follow

BIIB GO THE FCK UP YOU HOE

1
Reply
Share
Report
Save
Follow

bigly fcked on my BIIB calls. was up 30% yesterday before close and now the stock being down 1.5% makes them worth nothing apparently. even though IV only decreased by 10% img

1
Reply
Share
Report
Save
Follow

1k worth of $BIIB $300 calls .. #YOLOnotFOMO

1
Reply
Share
Report
Save
Follow

700$ in OTM BIIB calls for earnings

1
Reply
Share
Report
Save
Follow

Following companies reporting their earnings this week gonna short them All

$AAPL $INTC $AMZN $MSFT $META $GOOGL $UPS $SHOP $GM $KO $BA $F $XOM $GE $MMM $ENPH $V $JBLU $CMG $RTX $MCD $CAT $LUV $MA $SHW $PINS $BMY $MRK $BIIB $SPOT

1
Reply
Share
Report
Save
Follow

Implied moves for earnings next week:

​

$AAPL 5.4%
$AMZN 7.8%
$INTC 8.9%
$GOOGL 6.7%
$MSFT 5.6%
$META 12.9%
$SHOP 11.9%
$PINS 16.9%
$X 9.1%
$GILD 3.7%
$FSLR 9.1%
$DECK 12.9%
$DXCM 13.4%
$VRTX 4.1%
$EW 6.1%
$CAT 5.3%
$MCD 3.3%
$MA 4.9%
$LUV 5.8%
$MRK 3.5%
$WDC 9.4%
$HTZ 15.1%
$OSTK 13.8%
$AN 12.1%
$TDOC 18.1%
$F 7.6%
$NOW 8.1%
$V 5.1%
$ENPH 12.7%
$CMG 7.8%
$SPOT 12.2%
$TXN 6.1%
$FFIV 8.3%
$MAT 7.9%
$JNPR 6.3%
$BA 6.1%
$BMY 3.4%
$KHC 5.1%
$HLT 9.4%
$HOG 9.5%
$HES 5.7%
$STX 8.1%
$CME 4.0%
$GRMN 8.9%
$WING 16.2%
$CHEF 15.1%
$UPWK 21.1%
$ALGN 12.1%
$ORLY 7.3%
$VFC 8.1%
$LOGI 11.8%
$BRO 10.2%
$DFS 7.5%
$UPS 7.6%
$KO 3.5%
$GM 6.5%
$CLF 9.7%
$HAL 6.4%
$GE 6.1%
$MMM 5.2%
$JBLU 11.0%
$KMB 4.1%
$NVS 5.5%
$SHW 9.2%
$BIIB 5.4%
$TRU 10.1%
$PII 11.3%
$XRX 11.7%

1
Reply
Share
Report
Save
Follow

Implied moves for earnings next week:

​

$AAPL 5.4%
$AMZN 7.8%
$INTC 8.9%
$GOOGL 6.7%
$MSFT 5.6%
$META 12.9%
$SHOP 11.9%
$PINS 16.9%
$X 9.1%
$GILD 3.7%
$FSLR 9.1%
$DECK 12.9%
$DXCM 13.4%
$VRTX 4.1%
$EW 6.1%
$CAT 5.3%
$MCD 3.3%
$MA 4.9%
$LUV 5.8%
$MRK 3.5%
$WDC 9.4%
$HTZ 15.1%
$OSTK 13.8%
$AN 12.1%
$TDOC 18.1%
$F 7.6%
$NOW 8.1%
$V 5.1%
$ENPH 12.7%
$CMG 7.8%
$SPOT 12.2%
$TXN 6.1%
$FFIV 8.3%
$MAT 7.9%
$JNPR 6.3%
$BA 6.1%
$BMY 3.4%
$KHC 5.1%
$HLT 9.4%
$HOG 9.5%
$HES 5.7%
$STX 8.1%
$CME 4.0%
$GRMN 8.9%
$WING 16.2%
$CHEF 15.1%
$UPWK 21.1%
$ALGN 12.1%
$ORLY 7.3%
$VFC 8.1%
$LOGI 11.8%
$BRO 10.2%
$DFS 7.5%
$UPS 7.6%
$KO 3.5%
$GM 6.5%
$CLF 9.7%
$HAL 6.4%
$GE 6.1%
$MMM 5.2%
$JBLU 11.0%
$KMB 4.1%
$NVS 5.5%
$SHW 9.2%
$BIIB 5.4%
$TRU 10.1%
$PII 11.3%
$XRX 11.7%

1
Reply
Share
Report
Save
Follow

Need 10x or a 20x next week. I’m thinking Visa Puts, Ford Calls, UPS calls, BIIB Puts. Let’s home one of em hits

1
Reply
Share
Report
Save
Follow

NOC puts since it mirrored LMT’s chart, trading “in sympathy” with LMT because their earnings is supposed to be good.

Of course, every time I try this it fails regardless of the fact there was no good reason for the rally. Don’t know if that is true for NOC, I’m thinking about LLY running up just because they have an (unlikely to be viable) Alzheimer’s treatment in their pipeline when BIIB showed promising results.

1
Reply
Share
Report
Save
Follow

I was up $3k on like $600 of weed stock and didn’t sell 🤦‍♀️ that was my introduction to buying stock. I never know when to sell! And I hold so few that selling 1/2 to let it ride on house money seemed silly. If the market ever goes up again I will start pulling out my initial investments!! Did the same thing on biib and rocket lab

1
Reply
Share
Report
Save
Follow

Just a gamble that can pay off. Look m at REGN and BIIB both had huge moves off random news.

1
Reply
Share
Report
Save
Follow

Time to short BIIB?

1
Reply
Share
Report
Save
Follow

I bought calls just because it was cheaper than puts and I hope it goes up. BIIB puts screw me up today. My $260 puts expire today. BIIB was down to 258 and now it’s 269.

1
Reply
Share
Report
Save
Follow

if you guys want a good tip, when spy bottoms buy some BIIB 280 calls for 10/21

you're welcome

1
Reply
Share
Report
Save
Follow

BIIB puts

1
Reply
Share
Report
Save
Follow

I told you biib would go apeshit today. 😤

1
Reply
Share
Report
Save
Follow

BIIB is off on a tear. I’m an Osteopath Research Doc. The stock is so far past promising. Please take a position. It’s shown absolute facts as far as neurologists reports. Do yourself a massive favor.

1
Reply
Share
Report
Save
Follow

BIIB

1
Reply
Share
Report
Save
Follow

Yea, didn't BIIB also came up with a treatment few months ago that magically failed? They have a break through this time with a treatment that only causes bleeding in the brain, I mean, who doesn't want to bet on that?

1
Reply
Share
Report
Save
Follow

BIIB

1
Reply
Share
Report
Save
Follow

BioGen (Biib)

1
Reply
Share
Report
Save
Follow

It's hard for a massive company to go through the roof in one day. Even a massive new drug will only move them so much as part of their existing portfolio.

BIIB will likely move much more, if it hasn't already.

1
Reply
Share
Report
Save
Follow

BIIB holy fuck. We mooning boys.

1
Reply
Share
Report
Save
Follow

Dang who played BIIB this week?

1
Reply
Share
Report
Save
Follow

Yes on BIiB

1
Reply
Share
Report
Save
Follow

BIIB hulk dick green after alzheimers drug trial

1
Reply
Share
Report
Save
Follow

BIIB

1
Reply
Share
Report
Save
Follow

Damn BIIB up 50%

1
Reply
Share
Report
Save
Follow

Holy fkk BIIB. Anyone here caught that big move 🤯

1
Reply
Share
Report
Save
Follow

Anyone here have BIIB calls

1
Reply
Share
Report
Save
Follow

We all had BIIB calls ... right?

1
Reply
Share
Report
Save
Follow

BIIB 🚀

1
Reply
Share
Report
Save
Follow

I recommend that you avoid investing in this space as it is clear you don't understand it.

SAVA is up because all Alzheimer's companies are. Why? Because Biogen just announced incredible and unprecedented data on its 2nd Alzheimer's drug, Lecanemab. That's why the stock is halted. Not because of your day-old news about them settling the lawsuit.

When BIIB resumes trading tomorrow, expect it to hit ~$300.

1
Reply
Share
Report
Save
Follow

Watch BIIB, just sayin..

1
Reply
Share
Report
Save
Follow

BIIB, as of yesterday. No longer high risk.

1
Reply
Share
Report
Save
Follow

BIIB halted, Eisai Co. and partner Biogen Inc. said their Alzheimer’s drug lecanemab slowed the disease, becoming the first medicine to clearly blunt the progression of the most common type of dementia in a final-phase trial $BIIB

1
Reply
Share
Report
Save
Follow

If approved market cap won’t move as much as BIIB or LLY drugs because of inflation reduction act. Nearly every patient has Medicare in which they will negotiate a very low price with a yearly cap of 2000 a year.

1
Reply
Share
Report
Save
Follow

$SAVA has a Alzheimers drug well into Phase 3, and has enough cash on the B/S to bring it across the line. All they have to be is a bit better than Aricept (whose mechanism of action is still not fully understood), and it will be approved. LLY and BIIB MC has moved by $10B on Alzheimers news. MC should be in the $5B range imho

1
Reply
Share
Report
Save
Follow

Just wait 2 years, $1,000 plus. Just go and look at what happened to BIIB when their AZ drug got approved---up $20BIL in the day it was announced.

1
Reply
Share
Report
Save
Follow

He makes short term trades often. Another one that comes to mind is when he loaded up on BIIB prior to the Aduhelm FDA approval and then sold after the drug was approved.

1
Reply
Share
Report
Save
Follow

This stock---SAVA will fly. Their drug has been the only safe drug to show great cognitive results through phase 2 and they are in phase 3. This could be an absolute rocket to a $100 and if they get approved, could be a $1000 plus stock. Just look what BIIB did when they got approved for Alzheimers? Its market cap went up $20billion. SAVA!

1
Reply
Share
Report
Save
Follow

BIIB insiders still made a ton when their BS Alzheimer's drug was approved by the FDA last year.

1
Reply
Share
Report
Save
Follow

Check out CRTX, great hypotheses and data. Just need to work through liver effects. Way better than SAVA and BIIB and their fake data.

1
Reply
Share
Report
Save
Follow

>*BIOGEN RAISES FULL YEAR 2022 FINL GUIDANCE $BIIB

^*Walter ^Bloomberg ^@DeItaone ^at ^2022-07-20 ^06:59:54 ^EDT-0400

1
Reply
Share
Report
Save
Follow

$NFLX 14.7% LQ -35.1% LY -3.3%
$TSLA 7.8% LQ +3.2% LY -1.9%
$SNAP 18.5% LQ +1.2% LY +23.6%
$ISRG 6.8% LQ -14.3% LY -1.1%
$UAL 8.6%
$AAL 8.8%
$FCX 7.6%
$DPZ 6.5%
$TSCO 5.9%
$POOL 10.1%
$IQV 8.3%
$SAM 14.4%
$PPG 2.9%
$MAT 8.2%
$COF 6.2%
$STX 7.4%
$CLF 9.4%
$AXP 5.3%
$ROP 7.2%
$AA 8.9%
$CSX 4.9%
$LVS 7.4%
$KMI 3.8%
$EFX 9.4%
$CCI 7.0%
$JBHT 8.5%
$BAC 5.7%
$GS 4.5%
$IBM 5.9%
$ASML 6.3%
$ABT 3.6%
$NDAQ 6.4%
$BIIB 4.8%
$JNJ 2.6%
$LMT 4.0%
$HAS 9.3%
$SI 26.2%

1
Reply
Share
Report
Save
Follow

do you have a sheet with EarningsTtm for all 500+ S&P500 tickers? i am not sure where to find the mistake

|Ticker|SharesOutstanding|EarningsTtm| :--|:--|:--| |AAPL|16185000000|100347000000| |BRK.B|2206000000|81997020000| |GOOGL|658544000|73875465920| |GOOG|658544000|73875465920| |MSFT|7479000000|72172350000| |JPM|2937000000|39649500000| |META|2707000000|36246730000| |BAC|8057000000|28521780000| |XOM|4213000000|25404390000| |PFE|5611000000|24968950000| |INTC|4089000000|24779340000| |VZ|4200000000|21588000000| |AMZN|10174000000|21467140000| |CVX|1965000000|20966550000| |JNJ|2631000000|19837740000| |WFC|3790000000|18381500000| |GS|343447000|17965712570| |UNH|938172000|17374945440| |T|7159000000|17110010000| |C|1942000000|16584680000| |HD|1028000000|16262960000| |MRNA|397760000|14430732800| |PG|2399000000|14202080000| |MRK|2529000000|14187690000| |CMCSA|4480000000|14112000000| |MS|1749000000|13974510000| |V|2083000000|13289540000| |WMT|2741000000|12800470000| |COP|1293000000|12619680000| |ABBV|1767000000|12386670000| |CSCO|4141000000|11843260000| |F|4020000000|11617800000| |QCOM|1120000000|11099200000| |UPS|873766000|10764797120| |KO|4335000000|10360650000| |PEP|1383000000|10165050000| |COF|393051000|10038522540| |NVDA|2500000000|9450000000| |MA|972645000|9386024250| |AIG|792192000|9308256000| |MU|1117000000|8991850000| |PM|1550000000|8959000000| |GM|1458000000|8879220000| |TSLA|1036000000|8588440000| |AVGO|403818000|8484216180| |REGN|109846000|8237351540| |TXN|922134000|8170107240| |CB|423711000|8016612120| |CVS|1311000000|7957770000| |LOW|639129000|7867677990| |ABT|1751000000|7616850000| |TMO|391462000|7570875080| |AXP|753060000|7530600000| |NUE|266062000|7455057240| |MCD|739605000|7055831700| |ACN|664188000|6954048360| |USB|1486000000|6895040000| |DOW|728102000|6734943500| |ORCL|2668000000|6643320000| |UNP|628025000|6631944000| |AMAT|869947000|6576799320| |OXY|937191000|6504105540| |LLY|950160000|6423081600| |CAT|533374000|6405821740| |DHR|727077000|6398277600| |HCA|295484000|6382454400| |MET|813206000|6334874740| |WBA|863773000|6279629710| |BLK|151503000|6117691140| |BMY|2129000000|6046360000| |LMT|266107000|6045951040| |NKE|1574000000|6028420000| |TFC|1331000000|6016120000| |DE|305636000|5898774800| |HPQ|1034000000|5831760000| |LYB|327622000|5762870980| |TGT|463696000|5643180320| |NOC|155445000|5641099050| |COST|442963000|5638918990| |IBM|899435000|5531525250| |MMM|569059000|5519872300| |AMGN|534200000|5454182000| |WBD|2427000000|5412210000| |HON|680733000|5180378130| |CI|317273000|5165204440| |SCHW|1817000000|5051260000| |FCX|1449000000|5042520000| |NFLX|444274000|5015853460| |MDT|1329000000|4983750000| |DHI|352030000|4970663600| |PNC|413581000|4888527420| |ADBE|472500000|4866750000| |SPGI|347100000|4828161000| |CHTR|167858000|4765488620| |DFS|280965000|4742689200| |FDX|259178000|4704080700| |PRU|375000000|4657500000| |GILD|1254000000|4514400000| |LRCX|138715000|4463848700| |EOG|585713000|4416276020| |AMD|1621000000|4392910000| |LEN|295490000|4340748100| |SBUX|1147000000|4312720000| |PXD|241959000|4176212340| |RTX|1487000000|4163600000| |MDLZ|1384000000|4152000000| |TSN|354548000|4045392680| |ICE|558266000|4041845840| |PARA|649101000|4024426200| |LIN|503453000|3947071520| |AFL|644165000|3942289800| |NRG|237284000|3898576120| |TRV|239961000|3832177170| |CSX|2174000000|3826240000| |SYF|501489000|3726063270| |PLD|748939000|3722226830| |HPE|1299000000|3676170000| |DUK|769899000|3672418230| |PYPL|1158000000|3531900000| |DVN|660000000|3511200000| |ALL|274983000|3426288180| |ELV|357347000|3319753630| |EL|357347000|3319753630| |EMBC|357347000|3319753630| |BK|807798000|3279659880| |GD|277705000|3268587850| |TJX|1172000000|3234720000| |MMC|501914000|3212249600| |WTW|111488000|3196360960| |KLAC|149235000|3098118600| |ADM|562708000|3066758600| |EMR|621998000|2998030360| |HUM|126493000|2997884100| |D|830650000|2990340000| |MO|1811000000|2988150000| |NSC|238333000|2962479190| |AMP|109904000|2930040640| |ADP|417747000|2844857070| |TROW|227297000|2836666560| |TMUS|1254000000|2821500000| |PSX|481086000|2766244500| |CME|359421000|2760353280| |STT|367115000|2753362500| |FANG|177493000|2706768250| |AEP|513544000|2685835120| |WY|744498000|2680192800| |ITW|311443000|2662837650| |DIS|1821000000|2658660000| |AMT|456347000|2646812600| |CARR|848242000|2621067780| |EXC|980210000|2597556500| |MOS|361993000|2584630020| |VLO|408096000|2534276160| |INTU|282812000|2528339280| |MPC|540995000|2504806850| |ATVI|781882000|2486384760| |TEL|322174000|2458187620| |VRTX|255756000|2447584920| |HIG|328865000|2427023700| |FITB|686087000|2415026240| |KDP|1419000000|2412300000| |APA|338232000|2381153280| |MTB|179431000|2354134720| |CFG|495446000|2348414040| |KEY|932471000|2331177500| |SO|1063000000|2296080000| |GIS|602212000|2276361360| |RF|934500000|2270835000| |AZO|19488000|2262556800| |DG|226997000|2226840570| |DISH|529995000|2220679050| |ETN|399000000|2218440000| |CTSH|521174000|2178507320| |APD|221773000|2175593130| |PGR|584900000|2164130000| |SPG|328647000|2149351380| |LUMN|1033000000|2148640000| |NXPI|262565000|2145156050| |KR|727753000|2139593820| |SLB|1413000000|2105370000| |ORLY|65725000|2070337500| |ZTS|470629000|2061355020| |BBY|225168000|2051280480| |LH|93176000|2047076720| |CINF|160440000|2045610000| |CE|108309000|2039458470| |MRO|707691000|2038150080| |CL|837942000|2027819640| |SYK|378154000|2019342360| |PCAR|347683000|1981793100| |MCO|184500000|1961235000| |HSY|205605000|1951191450| |PHM|237627000|1943788860| |CBRE|326861000|1918674070| |CMI|141098000|1911877900| |WM|415207000|1893343920| |BEN|499924000|1864716520| |ADI|519806000|1850509360| |WDC|313168000|1841427840| |BDX|285065000|1821565350| |PSA|175529000|1816725150| |SHW|260131000|1815714380| |LHX|192875000|1809167500| |DGX|117365000|1793337200| |STX|214844000|1783205200| |SIVB|58851000|1760233410| |KMB|336925000|1752010000| |ABC|209464000|1736456560| |CTRA|805805000|1724422700| |IP|370629000|1701187110| |CTVA|723700000|1700695000| |PH|128478000|1688200920| |APH|597139000|1683931980| |FISV|646394000|1674160460| |ISRG|358957000|1651202200| |CF|208602000|1629181620| |XEL|544653000|1628512470| |CNP|629449000|1598800460| |YUM|285164000|1596918400| |VICI|963002000|1588953300| |L|246108000|1587396600| |ROST|349926000|1581665520| |RJF|216659000|1579444110| |HAL|901976000|1560418480| |EW|621752000|1535727440| |ED|354295000|1534097350| |URI|71612000|1531780680| |K|337873000|1530564690| |HOLX|249381000|1526211720| |DD|508527000|1525581000| |WHR|56202000|1524760260| |NTRS|208380000|1508671200| |OKE|446616000|1505095920| |CNC|584887000|1503159590| |PFG|252684000|1493362440| |MAR|327298000|1485932920| |DLTR|224556000|1482069600| |WMB|1218000000|1473780000| |EXPD|167754000|1466169960| |ON|434506000|1459940160| |CCI|433032000|1459317840| |NEE|1965000000|1454100000| |FRC|179603000|1436824000| |BIIB|146452000|1433765080| |TT|233860000|1424207400| |VFC|388323000|1378546650| |DLR|284672000|1377812480| |PAYX|361017000|1361034090| |WEC|315435000|1356370500| |MNST|529671000|1355957760| |AON|212384000|1350762240| |EQR|376042000|1349990780| |CMS|290129000|1349099850| |SWKS|160926000|1337295060| |RSG|315891000|1336218930| |NVR|3290000|1330081200| |MGM|426052000|1325021720| |WRB|265193000|1323313070| |RE|39438000|1320778620| |SWK|150965000|1305847250| |IVZ|455025000|1301371500| |OGN|253637000|1301157810| |ES|344878000|1300190060| |AWK|181753000|1286811240| |MCHP|554501000|1286442320| |MSI|167297000|1256400470| |A|298708000|1251586520| |OMC|205733000|1248799310| |OTIS|422794000|1238786420| |FE|570932000|1233213120| |KHC|1224000000|1224000000| |JCI|695669000|1210464060| |LNC|171947000|1191592710| |CTAS|102325000|1184923500| |NDAQ|164678000|1164273460| |GWW|51102000|1158482340| |AVB|139818000|1124136720| |DOV|144163000|1118704880| |ODFL|113354000|1117670440| |ROP|105913000|1115263890| |FOXA|556749000|1113498000| |FOX|556749000|1113498000| |BALL|319789000|1112865720| |ECL|285655000|1105484850| |CPRT|237673000|1083788880| |SBNY|62928000|1083620160| |GLW|844612000|1081103360| |GRMN|193125000|1077637500| |PPG|236194000|1072320760| |TAP|216890000|1071436600| |ETR|203374000|1069747240| |IQV|189279000|1069426350| |HBAN|1439000000|1064860000| |BAX|503529000|1062446190| |MCK|145365000|1061164500|

1
Reply
Share
Report
Save
Follow

Category 2 (part 2)

|Ticker|Name|Sector|Price|Market cap|P/E|Earnings date| :--|:--|:--|--:|--:|:-:|--:| |PNR|Pentair plc|Industrials|47.03|7778742986|14.4|07/26/2022| |META|Meta Platforms, Inc.|Communication Services|170.16|460507931590|12.88|07/27/2022| |TMO|Thermo Fisher Scientific Inc.|Healthcare|544.81|213272411264|28.37|07/27/2022| |MCD|McDonald's Corporation|Consumer Cyclical|247.9|183333696786|26.19|07/27/2022| |BMY|Bristol-Myers Squibb Company|Healthcare|78.96|168110891490|28.04|07/27/2022| |QCOM|QUALCOMM Incorporated|Technology|125.1|140111998291|12.81|07/27/2022| |NOW|ServiceNow, Inc.|Technology|504.09|101049779847|458.76|07/27/2022| |ADP|Automatic Data Processing, Inc.|Industrials|218.79|91398885204|32.31|07/27/2022| |PYPL|PayPal Holdings, Inc.|Financial|77.68|89956469873|25.68|07/27/2022| |BA|The Boeing Company|Industrials|141.53|83734214051|#N/A|07/27/2022| |CME|CME Group Inc.|Financial|210|75477801000|27.47|07/27/2022| |EQIX|Equinix, Inc.|Real Estate|689.17|62729485458|127.32|07/27/2022| |LRCX|Lam Research Corporation|Technology|450.19|62448106188|14.07|07/27/2022| |GD|General Dynamics Corporation|Industrials|222.33|61742175391|19.04|07/27/2022| |SHW|The Sherwin-Williams Company|Basic Materials|231.25|60155340000|33.68|07/27/2022| |HUM|Humana Inc.|Healthcare|456.81|57783449745|19.38|07/27/2022| |NSC|Norfolk Southern Corporation|Industrials|230.43|54918956229|18.61|07/27/2022| |MCO|Moody's Corporation|Financial|277.5|51198722250|26.29|07/27/2022| |F|Ford Motor Company|Consumer Cyclical|12.01|48277378570|4.22|07/27/2022| |ORLY|O'Reilly Automotive, Inc.|Consumer Cyclical|639.06|42002493135|20.47|07/27/2022| |APH|Amphenol Corporation|Technology|65.85|39321569313|24.43|07/27/2022| |TEL|TE Connectivity Ltd.|Technology|118.39|38142155985|15.67|07/27/2022| |CTSH|Cognizant Technology Solutions Corporation|Technology|70.26|36617672301|16.86|07/27/2022| |AFL|Aflac Incorporated|Financial|55.79|35937938044|9.16|07/27/2022| |HES|Hess Corporation|Energy|101.69|31652284384|43.6|07/27/2022| |ODFL|Old Dominion Freight Line, Inc.|Industrials|257.72|29213515702|26.32|07/27/2022| |VICI|VICI Properties Inc.|Real Estate|30.32|29198220346|18.75|07/27/2022| |AVB|AvalonBay Communities, Inc.|Real Estate|195.15|27285520876|24.33|07/27/2022| |DRE|Duke Realty Corporation|Real Estate|57.45|22086951533|21.44|07/27/2022| |HIG|The Hartford Financial Services Group, Inc.|Financial|65.69|21603116376|9.03|07/27/2022| |ALGN|Align Technology, Inc.|Healthcare|258.75|20390938650|29.15|07/27/2022| |RJF|Raymond James Financial, Inc.|Financial|92.5|20040920500|13.05|07/27/2022| |MAA|Mid-America Apartment Communities, Inc.|Real Estate|172.53|19914723687|33.53|07/27/2022| |GPC|Genuine Parts Company|Consumer Cyclical|136.75|19363129925|21.17|07/27/2022| |GRMN|Garmin Ltd.|Technology|100.13|19337605719|22.87|07/27/2022| |CINF|Cincinnati Financial Corporation|Financial|116.5|18681380800|9.24|07/27/2022| |URI|United Rentals, Inc.|Industrials|248.29|17780421337|11.67|07/27/2022| |TDY|Teledyne Technologies Incorporated|Technology|378.02|17707537422|31.16|07/27/2022| |HOLX|Hologic, Inc.|Healthcare|70.93|17688594406|11.68|07/27/2022| |IR|Ingersoll Rand Inc.|Industrials|43.33|17588938977|23.96|07/27/2022| |ROL|Rollins, Inc.|Consumer Cyclical|35.11|17290288455|52.28|07/27/2022| |MOH|Molina Healthcare, Inc.|Healthcare|267.13|15680533957|22.72|07/27/2022| |UDR|UDR, Inc.|Real Estate|46.15|14694206635|91.76|07/27/2022| |GNRC|Generac Holdings Inc.|Industrials|224.55|14333010976|29.75|07/27/2022| |TYL|Tyler Technologies, Inc.|Technology|345.33|14322112264|88.88|07/27/2022| |AVY|Avery Dennison Corporation|Industrials|165.35|13511451736|18.94|07/27/2022| |PTC|PTC Inc.|Technology|112.44|13152770481|27.8|07/27/2022| |RE|Everest Re Group, Ltd.|Financial|283.19|11168433156|8.42|07/27/2022| |LW|Lamb Weston Holdings, Inc.|Consumer Defensive|71.91|10387169916|44.86|07/27/2022| |FBHS|Fortune Brands Home & Security, Inc.|Consumer Cyclical|63.24|8272253871|11.27|07/27/2022| |VRSN|VeriSign, Inc.|Technology|169.27|18542631837|23.79|07/28/2022| |PFE|Pfizer Inc.|Healthcare|51.59|289466125496|11.84|07/28/2022| |MRK|Merck & Co., Inc.|Healthcare|93.13|235507602704|16.66|07/28/2022| |ABT|Abbott Laboratories|Healthcare|109.45|191640596556|25.27|07/28/2022| |CMCSA|Comcast Corporation|Communication Services|39.57|177274192182|12.74|07/28/2022| |INTC|Intel Corporation|Technology|38.61|157876253885|6.42|07/28/2022| |HON|Honeywell International Inc.|Industrials|180.02|122545575570|34.79|07/28/2022| |MO|Altria Group, Inc.|Consumer Defensive|43.4|78578176562|26.44|07/28/2022| |NEM|Newmont Corporation|Basic Materials|64.18|50936527840|48.63|07/28/2022| |AEP|American Electric Power Company, Inc.|Utilities|93.6|48067736336|17.96|07/28/2022| |FCX|Freeport-McMoRan Inc.|Basic Materials|30.99|44912629048|8.99|07/28/2022| |VLO|Valero Energy Corporation|Energy|103.93|42413458976|16.73|07/28/2022| |BAX|Baxter International Inc.|Healthcare|66.78|33625639293|32.02|07/28/2022| |BIIB|Biogen Inc.|Healthcare|211.93|31037571287|21.72|07/28/2022| |TWTR|Twitter, Inc.|Communication Services|39.41|30116357329|162.78|07/28/2022| |NUE|Nucor Corporation|Basic Materials|111.06|29548833964|3.96|07/28/2022| |TROW|T. Rowe Price Group, Inc.|Financial|121.5|27616524750|9.83|07/28/2022| |SIVB|SVB Financial Group|Financial|415.52|24453829201|14.1|07/28/2022| |FITB|Fifth Third Bancorp|Financial|35.22|24163995543|10.09|07/28/2022| |LUV|Southwest Airlines Co.|Industrials|37.73|22372248473|40|07/28/2022| |FE|FirstEnergy Corp.|Utilities|37.29|21290065989|16.66|07/28/2022| |DPZ|Domino's Pizza, Inc.|Consumer Cyclical|396.54|14293312365|30.31|07/28/2022| |POOL|Pool Corporation|Consumer Cyclical|356.94|14286495042|19.79|07/28/2022| |CE|Celanese Corporation|Basic Materials|127.57|13816953582|6.83|07/28/2022| |KIM|Kimco Realty Corporation|Real Estate|20.14|12446656574|12.77|07/28/2022| |SNA|Snap-on Incorporated|Industrials|201.87|10774661605|13.08|07/28/2022| |AAL|American Airlines Group Inc.|Industrials|13.9|9028255472|#N/A|07/28/2022| |ALLE|Allegion plc|Industrials|99.6|8745368902|19.14|07/28/2022| |RHI|Robert Half International Inc.|Industrials|77.9|8609001818|13.2|07/28/2022| |ALK|Alaska Air Group, Inc.|Industrials|41.92|5285768025|11.45|07/28/2022| |XOM|Exxon Mobil Corporation|Energy|86.9|366127520928|14.4|07/29/2022| |PG|The Procter & Gamble Company|Consumer Defensive|144.35|346338392244|25.23|07/29/2022| |CVX|Chevron Corporation|Energy|144.77|284445986404|13.61|07/29/2022| |ABBV|AbbVie Inc.|Healthcare|152.34|269201530928|21.85|07/29/2022| |LIN|Linde plc|Basic Materials|303.23|152441155658|39.02|07/29/2022| |CAT|Caterpillar Inc.|Industrials|185.49|98935601836|15.56|07/29/2022| |CHTR|Charter Communications, Inc.|Communication Services|463.12|88684051976|16.77|07/29/2022| |CL|Colgate-Palmolive Company|Consumer Defensive|80.38|67353759582|33.3|07/29/2022| |ITW|Illinois Tool Works Inc.|Industrials|187.92|58526349197|22.09|07/29/2022| |AON|Aon plc|Financial|271.74|57713171737|43.16|07/29/2022| |PSX|Phillips 66|Energy|84.2|40508610111|14.65|07/29/2022| |JCI|Johnson Controls International plc|Industrials|48.95|34052988290|28.37|07/29/2022| |IDXX|IDEXX Laboratories, Inc.|Healthcare|361.48|30366934423|42.43|07/29/2022| |LYB|LyondellBasell Industries N.V.|Basic Materials|89.24|29236968732|5.07|07/29/2022| |WY|Weyerhaeuser Company|Real Estate|34.33|25558610837|9.55|07/29/2022| |GWW|W.W. Grainger, Inc.|Industrials|460.95|23555315410|20.4|07/29/2022| |CHD|Church & Dwight Co., Inc.|Consumer Defensive|91.61|22240251458|28.1|07/29/2022| |VFC|V.F. Corporation|Consumer Cyclical|48.01|18650904943|15.49|07/29/2022| |CBOE|Cboe Global Markets, Inc.|Financial|114.94|12205317943|24.61|07/29/2022| |NWL|Newell Brands Inc.|Consumer Defensive|20.03|8282405283|#N/A|07/29/2022| |CTRA|Coterra Energy Inc.|Energy|26.35|479941278|32.7|07/29/2022|

1
Reply
Share
Report
Save
Follow

Category 2 (part 2)

|Ticker|Name|Sector|Price|Market cap|P/E|Earnings date| :--|:--|:--|--:|--:|:-:|--:| |PNR|Pentair plc|Industrials|47.03|7778742986|14.4|07/26/2022| |META|Meta Platforms, Inc.|Communication Services|170.16|460507931590|12.88|07/27/2022| |TMO|Thermo Fisher Scientific Inc.|Healthcare|544.81|213272411264|28.37|07/27/2022| |MCD|McDonald's Corporation|Consumer Cyclical|247.9|183333696786|26.19|07/27/2022| |BMY|Bristol-Myers Squibb Company|Healthcare|78.96|168110891490|28.04|07/27/2022| |QCOM|QUALCOMM Incorporated|Technology|125.1|140111998291|12.81|07/27/2022| |NOW|ServiceNow, Inc.|Technology|504.09|101049779847|458.76|07/27/2022| |ADP|Automatic Data Processing, Inc.|Industrials|218.79|91398885204|32.31|07/27/2022| |PYPL|PayPal Holdings, Inc.|Financial|77.68|89956469873|25.68|07/27/2022| |BA|The Boeing Company|Industrials|141.53|83734214051|#N/A|07/27/2022| |CME|CME Group Inc.|Financial|210|75477801000|27.47|07/27/2022| |EQIX|Equinix, Inc.|Real Estate|689.17|62729485458|127.32|07/27/2022| |LRCX|Lam Research Corporation|Technology|450.19|62448106188|14.07|07/27/2022| |GD|General Dynamics Corporation|Industrials|222.33|61742175391|19.04|07/27/2022| |SHW|The Sherwin-Williams Company|Basic Materials|231.25|60155340000|33.68|07/27/2022| |HUM|Humana Inc.|Healthcare|456.81|57783449745|19.38|07/27/2022| |NSC|Norfolk Southern Corporation|Industrials|230.43|54918956229|18.61|07/27/2022| |MCO|Moody's Corporation|Financial|277.5|51198722250|26.29|07/27/2022| |F|Ford Motor Company|Consumer Cyclical|12.01|48277378570|4.22|07/27/2022| |ORLY|O'Reilly Automotive, Inc.|Consumer Cyclical|639.06|42002493135|20.47|07/27/2022| |APH|Amphenol Corporation|Technology|65.85|39321569313|24.43|07/27/2022| |TEL|TE Connectivity Ltd.|Technology|118.39|38142155985|15.67|07/27/2022| |CTSH|Cognizant Technology Solutions Corporation|Technology|70.26|36617672301|16.86|07/27/2022| |AFL|Aflac Incorporated|Financial|55.79|35937938044|9.16|07/27/2022| |HES|Hess Corporation|Energy|101.69|31652284384|43.6|07/27/2022| |ODFL|Old Dominion Freight Line, Inc.|Industrials|257.72|29213515702|26.32|07/27/2022| |VICI|VICI Properties Inc.|Real Estate|30.32|29198220346|18.75|07/27/2022| |AVB|AvalonBay Communities, Inc.|Real Estate|195.15|27285520876|24.33|07/27/2022| |DRE|Duke Realty Corporation|Real Estate|57.45|22086951533|21.44|07/27/2022| |HIG|The Hartford Financial Services Group, Inc.|Financial|65.69|21603116376|9.03|07/27/2022| |ALGN|Align Technology, Inc.|Healthcare|258.75|20390938650|29.15|07/27/2022| |RJF|Raymond James Financial, Inc.|Financial|92.5|20040920500|13.05|07/27/2022| |MAA|Mid-America Apartment Communities, Inc.|Real Estate|172.53|19914723687|33.53|07/27/2022| |GPC|Genuine Parts Company|Consumer Cyclical|136.75|19363129925|21.17|07/27/2022| |GRMN|Garmin Ltd.|Technology|100.13|19337605719|22.87|07/27/2022| |CINF|Cincinnati Financial Corporation|Financial|116.5|18681380800|9.24|07/27/2022| |URI|United Rentals, Inc.|Industrials|248.29|17780421337|11.67|07/27/2022| |TDY|Teledyne Technologies Incorporated|Technology|378.02|17707537422|31.16|07/27/2022| |HOLX|Hologic, Inc.|Healthcare|70.93|17688594406|11.68|07/27/2022| |IR|Ingersoll Rand Inc.|Industrials|43.33|17588938977|23.96|07/27/2022| |ROL|Rollins, Inc.|Consumer Cyclical|35.11|17290288455|52.28|07/27/2022| |MOH|Molina Healthcare, Inc.|Healthcare|267.13|15680533957|22.72|07/27/2022| |UDR|UDR, Inc.|Real Estate|46.15|14694206635|91.76|07/27/2022| |GNRC|Generac Holdings Inc.|Industrials|224.55|14333010976|29.75|07/27/2022| |TYL|Tyler Technologies, Inc.|Technology|345.33|14322112264|88.88|07/27/2022| |AVY|Avery Dennison Corporation|Industrials|165.35|13511451736|18.94|07/27/2022| |PTC|PTC Inc.|Technology|112.44|13152770481|27.8|07/27/2022| |RE|Everest Re Group, Ltd.|Financial|283.19|11168433156|8.42|07/27/2022| |LW|Lamb Weston Holdings, Inc.|Consumer Defensive|71.91|10387169916|44.86|07/27/2022| |FBHS|Fortune Brands Home & Security, Inc.|Consumer Cyclical|63.24|8272253871|11.27|07/27/2022| |VRSN|VeriSign, Inc.|Technology|169.27|18542631837|23.79|07/28/2022| |PFE|Pfizer Inc.|Healthcare|51.59|289466125496|11.84|07/28/2022| |MRK|Merck & Co., Inc.|Healthcare|93.13|235507602704|16.66|07/28/2022| |ABT|Abbott Laboratories|Healthcare|109.45|191640596556|25.27|07/28/2022| |CMCSA|Comcast Corporation|Communication Services|39.57|177274192182|12.74|07/28/2022| |INTC|Intel Corporation|Technology|38.61|157876253885|6.42|07/28/2022| |HON|Honeywell International Inc.|Industrials|180.02|122545575570|34.79|07/28/2022| |MO|Altria Group, Inc.|Consumer Defensive|43.4|78578176562|26.44|07/28/2022| |NEM|Newmont Corporation|Basic Materials|64.18|50936527840|48.63|07/28/2022| |AEP|American Electric Power Company, Inc.|Utilities|93.6|48067736336|17.96|07/28/2022| |FCX|Freeport-McMoRan Inc.|Basic Materials|30.99|44912629048|8.99|07/28/2022| |VLO|Valero Energy Corporation|Energy|103.93|42413458976|16.73|07/28/2022| |BAX|Baxter International Inc.|Healthcare|66.78|33625639293|32.02|07/28/2022| |BIIB|Biogen Inc.|Healthcare|211.93|31037571287|21.72|07/28/2022| |TWTR|Twitter, Inc.|Communication Services|39.41|30116357329|162.78|07/28/2022| |NUE|Nucor Corporation|Basic Materials|111.06|29548833964|3.96|07/28/2022| |TROW|T. Rowe Price Group, Inc.|Financial|121.5|27616524750|9.83|07/28/2022| |SIVB|SVB Financial Group|Financial|415.52|24453829201|14.1|07/28/2022| |FITB|Fifth Third Bancorp|Financial|35.22|24163995543|10.09|07/28/2022| |LUV|Southwest Airlines Co.|Industrials|37.73|22372248473|40|07/28/2022| |FE|FirstEnergy Corp.|Utilities|37.29|21290065989|16.66|07/28/2022| |DPZ|Domino's Pizza, Inc.|Consumer Cyclical|396.54|14293312365|30.31|07/28/2022| |POOL|Pool Corporation|Consumer Cyclical|356.94|14286495042|19.79|07/28/2022| |CE|Celanese Corporation|Basic Materials|127.57|13816953582|6.83|07/28/2022| |KIM|Kimco Realty Corporation|Real Estate|20.14|12446656574|12.77|07/28/2022| |SNA|Snap-on Incorporated|Industrials|201.87|10774661605|13.08|07/28/2022| |AAL|American Airlines Group Inc.|Industrials|13.9|9028255472|#N/A|07/28/2022| |ALLE|Allegion plc|Industrials|99.6|8745368902|19.14|07/28/2022| |RHI|Robert Half International Inc.|Industrials|77.9|8609001818|13.2|07/28/2022| |ALK|Alaska Air Group, Inc.|Industrials|41.92|5285768025|11.45|07/28/2022| |XOM|Exxon Mobil Corporation|Energy|86.9|366127520928|14.4|07/29/2022| |PG|The Procter & Gamble Company|Consumer Defensive|144.35|346338392244|25.23|07/29/2022| |CVX|Chevron Corporation|Energy|144.77|284445986404|13.61|07/29/2022| |ABBV|AbbVie Inc.|Healthcare|152.34|269201530928|21.85|07/29/2022| |LIN|Linde plc|Basic Materials|303.23|152441155658|39.02|07/29/2022| |CAT|Caterpillar Inc.|Industrials|185.49|98935601836|15.56|07/29/2022| |CHTR|Charter Communications, Inc.|Communication Services|463.12|88684051976|16.77|07/29/2022| |CL|Colgate-Palmolive Company|Consumer Defensive|80.38|67353759582|33.3|07/29/2022| |ITW|Illinois Tool Works Inc.|Industrials|187.92|58526349197|22.09|07/29/2022| |AON|Aon plc|Financial|271.74|57713171737|43.16|07/29/2022| |PSX|Phillips 66|Energy|84.2|40508610111|14.65|07/29/2022| |JCI|Johnson Controls International plc|Industrials|48.95|34052988290|28.37|07/29/2022| |IDXX|IDEXX Laboratories, Inc.|Healthcare|361.48|30366934423|42.43|07/29/2022| |LYB|LyondellBasell Industries N.V.|Basic Materials|89.24|29236968732|5.07|07/29/2022| |WY|Weyerhaeuser Company|Real Estate|34.33|25558610837|9.55|07/29/2022| |GWW|W.W. Grainger, Inc.|Industrials|460.95|23555315410|20.4|07/29/2022| |CHD|Church & Dwight Co., Inc.|Consumer Defensive|91.61|22240251458|28.1|07/29/2022| |VFC|V.F. Corporation|Consumer Cyclical|48.01|18650904943|15.49|07/29/2022| |CBOE|Cboe Global Markets, Inc.|Financial|114.94|12205317943|24.61|07/29/2022| |NWL|Newell Brands Inc.|Consumer Defensive|20.03|8282405283|#N/A|07/29/2022| |CTRA|Coterra Energy Inc.|Energy|26.35|479941278|32.7|07/29/2022|

1
Reply
Share
Report
Save
Follow

Short BIIB and SEDG. Don't expect to cash out of these until later in the week. Will probably increase them if they move hard upwards.

1
Reply
Share
Report
Save
Follow

Like BIIB and CRSP?

1
Reply
Share
Report
Save
Follow

Here are a few reasons why I don't buy QQQ:
AMZN

TSLA

NVDA

FB

COST

PEP

AVGO

CSCO

CMCSA

ADBE

INTC

TMUS

TXN

QCOM

AMGN

AMD

HON

INTU

PYPL

AMAT

ADP

BKNG

MDLZ

SBUX

ISRG

NFLX

CHTR

ADI

GILD

CSX

MU

REGN

VRTX

FISV

LRCX

ATVI

MAR

MRNA

PANW

ABNB

KDP

KHC

MELI

AEP

FTNT

MRVL

ORLY

KLAC

PAYX

EXC

ILMN

ASML

MNST

NXPI

SNPS

LULU

CTSH

CDNS

CRWD

CTAS

WDAY

DXCM

XEL

ADSK

WBA

AZN

IDXX

DLTR

MCHP

ROST

TEAM

JD

EA

VRSK

FAST

DDOG

ODFL

EBAY

BIIB

LCID

PCAR

ZS

BIDU

ALGN

CPRT

SGEN

ZM

SIRI

ANSS

VRSN

MTCH

CEG

SPLK

OKTA

NTES

SWKS

PDD

DOCU

1
Reply
Share
Report
Save
Follow

You missed the 50-page DD written by myself, an associate professor of internal medicine, and other PhDs, MDs, pharmacologists, and Investors.

The only thing silly here is your lack of nuance when criticizing an in-depth analysis. IMO, there is a 90% chance of FDA approval based on 440 data points, reviewing 6 papers on why drugs fail P3, etc.

Comparing Simufilam to BIIB highlights your lack of attention to detail. Lastly, you circle that shit by comparing 2 decades of research largely focused on the amyloid hypothesis.

1
Reply
Share
Report
Save
Follow

It does tell you how desperate AD patients are that they are still taking BIIB.

1
Reply
Share
Report
Save
Follow

U

W

BIIB

COIN

MARA

DASH*

GME

AMC

RBLX

TSLA

LCID

RIVN

SQQQ/QQQ

ARKK/SARK

TDOC*

SOFI

PTON

PINS

LYFT

UBER*

WISH

NKLA

PLUG

SPCE

1
Reply
Share
Report
Save
Follow

I hope you loaded up on puts yesterday when cramer said he likes Lilly $BIIB💪🏼💪🏼inverse that crackhead and gains are almost guaranteed

1
Reply
Share
Report
Save
Follow

The following stocks are only 4% from their peak. Weathered this correction strongly!

VLO -3.95% KO -3.85% BMY -3.71% XEL -3.67% WM -3.37% JNJ -3.34% PEP -3.33% MRK -2.96% PG -2.90% MO -2.59% HSY -2.52% K -2.44% CERN -0.36%

The following stocks are down over 50% from their peak. Clobbered!

MRNA -72.98% NFLX -72.84% PYPL -71.65% ETSY -69.72% GPS -66.99% PENN -61.69% ALGN -60.69% IPGP -59.37% GNRC -58.16% CDAY -56.95% MTCH -56.51% BIIB -55.73%

1
Reply
Share
Report
Save
Follow

Really, Wow not what I get.

Symbol,Impl Vol,IVRank,Mark,Net Chng ABNB,76.07%,88.9,153.700,-6.53 AKAM,45.87%,73.6,112.280,-3.55 AMD,76.12%,93.9,85.870,-4.12 ANET,68.13%,85.8,116.000,-5.34 BIGC,111.37%,65.9,17.880,-.80 BIIB,44.72%,13.4,207.530,-2.97 BKNG,60.49%,100.0,2211.110,-107.49 BP,51.99%,72.1,28.720,-.63 CAR,112.29%,45.5,267.670,-5.38 CHGG,99.89%,59.1,24.740,-.96 CROX,85.46%,92.3,66.750,-1.39 CVS,39.80%,100.0,96.130,-4.72 DASH,118.61%,99.8,81.540,-5.96 DBX,63.60%,67.6,21.750,-.71 DDOG,99.44%,94.7,121.500,-7.69 DOCN,132.76%,100.0,39.430,-4.57 EAT,79.91%,100.0,36.380,-2.51 EL,50.39%,100.0,264.060,-8.27 ETSY,103.88%,99.7,93.660,-8.69 EXPE,70.39%,99.3,175.330,-8.65 EXPI,113.63%,87.1,13.390,-.63 FSLY,132.96%,95.9,15.950,-1.20 FTNT,71.78%,97.3,289.500,-19.64 FUBO,160.15%,94.0,3.790,-.28 GDDY,54.04%,81.4,80.810,-6.52 IPI,109.87%,75.8,76.580,-6.48 IRBT,93.85%,89.0,50.650,+.29 LOGI,60.70%,68.2,65.300,-.70 LYFT,82.42%,85.9,32.720,-.96 MELI,85.58%,91.7,975.060,-66.37 MGM,58.46%,78.3,41.060,-1.07 MGNI,110.35%,73.5,9.650,-.60 MOS,80.75%,96.2,62.450,-2.90 MRNA,91.72%,72.1,135.000,-8.11 MTCH,82.66%,98.4,79.350,-2.45 NET,107.20%,96.9,86.260,-9.11 NTR,60.94%,91.1,98.250,-3.05 PENN,86.45%,89.9,36.700,-1.31 PFE,44.17%,88.3,48.680,-1.44 PRU,41.91%,71.6,108.510,-3.61 QSR,37.08%,89.9,57.150,-1.27 RACE,44.88%,71.8,209.740,-4.30 REGN,36.55%,76.6,659.210,-16.47 SBUX,47.33%,99.2,74.750,-1.94 SHAK,77.83%,96.9,57.830,-2.33 SHOP,104.01%,97.5,428.050,-16.46 SKLZ,152.62%,50.0,2.060,-.14 SQ,105.42%,93.6,99.800,-5.10 SWKS,64.64%,100.0,113.350,-4.35 TRIP,71.02%,66.6,25.670,-.69 TUP,87.47%,68.2,17.580,-.25 TWLO,103.28%,100.0,111.820,-7.10 UBER,79.30%,96.5,31.480,-1.34 VRTX,35.17%,30.5,273.220,+4.58 W,120.04%,97.2,77.020,-6.45 WING,74.37%,95.7,91.760,-6.02 YUM,38.07%,88.1,117.010,-2.51 ZBRA,52.01%,89.8,370.010,-13.32 ZG,94.13%,97.0,38.650,-.96 ZI,81.83%,88.1,47.400,-1.55

1
Reply
Share
Report
Save
Follow

Some implied ones for earnings next week - 1607 companies reporting : $SQ 15.8% $ZG 18.6% $DASH 18.5% $FUBO 22.4% $MELI 12.1% $DBX 9.2% $SHAK 15.5% $VRTX 5.0% $SHOP 14.6% $DDOG 15.6% $UBER 11.9% $TWLO 16.9% $ETSY 17.5% $NET 15.7% $FSLY 20.0% $SKLZ 26.8% $TRIP 11.5% $FTNT 14.0% $IRBT 18.7% $BKNG 8.8% $DOCN 24.9% $MGNI 20.7% $GDDY 10.6% $CROX 16.9% $PENN 11.1% $W 19.1% $AMD 10.9% $ABNB 10.7% $SBUX 6.7% $LYFT 12.8% $SWKS 9.4% $MTCH 10.7% $AKAM 7.7% $PRU 7.3% $MRNA 12.4% $CVS 5.2% $REGN 6.7% $YUM 5.0% $WING 13.2% $RACE 6.1% $EAT 14.2% $EXPI 21.5% $TUP 17.1% $CHGG 20.2% $CAR 18.7% $EXPE 10.6% $LOGI 11.3% $MGM 7.7% ?$ANET 11.2% $MOS 10.9% $ZI 16.3% $NTR 8.5% $IPI 20.9% $BIGC 21.5% $PFE 6.0% $BP 6.1% $BIIB 5.9% $QSR 6.8% ?$EL 9.7% $ZBRA 10.1%

1
Reply
Share
Report
Save
Follow

Just one, Biogen (BIIB)

I usually do a ton of DD before committing any kind of money but I like this stock.

1
Reply
Share
Report
Save
Follow

since when -1% needs to be in the news?

Biogen (BIIB) – Biogen fell 1% in premarket trading after the government announced that Medicare will limit coverage for Aduhelm, Biogen’s Alzheimer’s disease treatment. Coverage will only be provided for patients enrolled in clinical trials.

1
Reply
Share
Report
Save
Follow

Biogen, $BIIB, files final protocol with FDA for Alzheimer’s drug Aduhelm confirmatory trial.

Biden: let me test this shit [laughing]

1
Reply
Share
Report
Save
Follow

whats up with BIIB? it's right at the bottom of a price range that been there for years, is this a good opportunity? or is the threat that it falls out this range too much to risk?

1
Reply
Share
Report
Save
Follow

BIIB will buy out SAVA EOY. Mark my words

1
Reply
Share
Report
Save
Follow

Some implied moves for #earnings next week - 526 companies reporting:
$FB 6.7%
$GOOGL 5.7%
$AMZN 5.6%
$SNAP 17.8%
$PYPL 8.1%
$SBUX 5.1%
$AMD 9.3%
$SPOT 10.7%
$QCOM 8.2%
$ALGN 10.8%
$PENN 11.7%
$REGN 6.8%
$RCL 11.8%
$BIIB 5.1%
$MRK 3.4%
$EL 8.2%
$RL 7.1%
$CHKP 7.0%
$PINS 16.2%
$F 8.3%
$U 13.2%
$SWKS 7.8%
$SKX 10.4%
$FTNT 12.1%
$DECK 11.0%
$WWE 10.1%
$EA 6.4%
$GILD 5.4%
$MTCH 9.4%
$ABBV 3.9%
$RACE 5.6%
$BSX 6.4%
$CPRI 9.8%
$NXPI 7.0%
$UPS 6.5%
$XOM 4.3%
$SMG 9.4%
$SWK 7.7%

1
Reply
Share
Report
Save
Follow

Some implied moves for #earnings next week - 526 companies reporting:

​

$FB 6.7%
$GOOGL 5.7%
$AMZN 5.6%
$SNAP 17.8%
$PYPL 8.1%
$SBUX 5.1%
$AMD 9.3%
$SPOT 10.7%
$QCOM 8.2%
$ALGN 10.8%
$PENN 11.7%
$REGN 6.8%
$RCL 11.8%
$BIIB 5.1%
$MRK 3.4%
$EL 8.2%
$RL 7.1%
$CHKP 7.0%
$PINS 16.2%
$F 8.3%
$U 13.2%
$SWKS 7.8%
$SKX 10.4%
$FTNT 12.1%
$DECK 11.0%
$WWE 10.1%
$EA 6.4%
$GILD 5.4%
$MTCH 9.4%
$ABBV 3.9%
$RACE 5.6%
$BSX 6.4%
$CPRI 9.8%
$NXPI 7.0%
$UPS 6.5%
$XOM 4.3%
$SMG 9.4%
$SWK 7.7%

1
Reply
Share
Report
Save
Follow

I can provide you some in-dept DD later but if you're looking for fundamentally solid stocks that are trading at reasonable multiples and would do well in a rising interest rate environment I would consider things like INTC, Pharma names like (BMY, GILD, BIIB), safe tech/ 5G (T, VZ), recovery (CCL, BA, NCLH, LUV), a financial etf like the XLF or buying quality individual names like MS, GS, JPM, WFC, and so on.

Lastly, it's good to have some foreign market exposure so something like BABA, JD, TCEHY, or STNE is good.

This is not financial advice.

1
Reply
Share
Report
Save
Follow

Very fair! I was thinking tech feels more risky, and moved some funds from smaller cap tech stocks to larger. Still want the diversity, but felt smaller cap would face larger struggles if inflation continues to spiral and we see more rate hikes. Also with a new year I wanted to buy more ibonds. I also sold an asset management company, because my theory would have played out already if it was going to come to fruition. That fin company was 1.5% of my portfolio, and I sold at a -12% loss… I don’t sell all my losers I’m still bag holding BIIB at -15%, and DIS.

1
Reply
Share
Report
Save
Follow

Yeah. First, it makes the drug appear to have more effect, 1.1 pts in this case. Because they stopped sharing baselines after receiving this criticism, we don’t know what’s happening in later days disclosures. This was how the BIIB drug arguably got most of its effects- more apoe4 carriers dropped and they decline faster than others. Anyway, this skews data and being not transparent about what is going on makes it worse.

Second issue is that you want the trial to have largely similar patients to be a good trial design. This is exactly not that.

1
Reply
Share
Report
Save
Follow

Shorting biotech is pretty free money esp in AD. Puts on biib or crtx was just free cash, both bad companies theres a lot of them in biotech

1
Reply
Share
Report
Save
Follow

I suspected the price action reflects investors sentiment associated with $BIIB and their products more so than their views of $SAVA itself. The underlying premise of $BIIB drug is to remove aggregated plaques with targeting antibodies and there is not effect. Having plaques that can autocatalyze while augmenting the protein folding response will not address the underlying issue. I also acknowledge that he field is still unsure if it’s the presence of large plaques vs generation of the plaques and resulting cell death is the causative factor. Nevertheless, the price action may not just be a reflection of this report

1
Reply
Share
Report
Save
Follow

Biib

1
Reply
Share
Report
Save
Follow

Here's another from r/investing

​

|ticker| | |
|:-|:-|:-|
|IPO|0.897867|3|
|LMAO|0.772333|3|
|BRK.B|0.7339|3|
|RE|0.6208|4|
|TV|0.530017|6|
|DD|0.50746|5|
|FB|0.504667|9|
|MVIS|0.4885|3|
|AI|0.46698|5|
|MS|0.462433|3|
|GL|0.446067|3|
|QQQ|0.439367|9|
|BIIB|0.414933|3|
|PLTR|0.4074|8|
|NYC|0.39298|5|
|IQ|0.385967|3|
|TQQQ|0.3746|4|
|BB|0.3696|4|
|RRR|0.367946|13|
|TTM|0.3373|3|
|AAPL|0.314617|18|
|NET|0.298|4|
|USA|0.293213|15|
|SE|0.289267|6|
|AMD|0.275089|27|
|AND|0.27355|6|
|WISH|0.2671|3|
|OR|0.2604|3|
|CPI|0.25644|10|
|IMO|0.246925|8|
|TSLA|0.240779|14|
|NVDA|0.237017|6|
|AMZN|0.175875|4|
|CD|0.175325|8|
|AMC|0.1741|3|
|OP|0.172806|32|
|TD|0.16258|5|
|MSFT|0.156154|13|
|REIT|0.1469|3|
|IBKR|0.120475|4|
|VERY|0.079367|3|
|DM|0.0706|4|
|GME|0.042729|34|
|SQ|0.0369|5|
|IS|0.0183|5|
|HIMX|0.012925|4|
|JPM|-0.06338|8|
|BABA|-0.08628|8|
|ETC|-0.1001|3|
|TA|-0.1199|5|
|UK|-0.13508|4|
|IRS|-0.1822|4|
|TIL|-0.1891|4|
|ALL|-0.21113|4|
|NVAX|-0.4499|3|
^Table ^formatting ^brought ^to ^you ^by ^[ExcelToReddit](https://xl2reddit.github.io/)

1
Reply
Share
Report
Save
Follow

BIIB is about as unethical as any entity can be. To have a drug you know doesn’t work but in fact causes damage, and then to go and charge that amount for it? Lol, they didn’t even work over time (I walk right passed and live down the street from) at corporate during what should have been a crises.

There are a few actually promising AD companies/drugs in the works. Actually my largest single position is one because I know it well. T is good, I went in heavy there in Q4, 2021.

1
Reply
Share
Report
Save
Follow

> BIIB will be volatile until there’s more clarity on whether a market exists for its Alzheimer drug

I was under the impression that Aduhelm essentially doesn't work; regardless of whether it was cheap or not, it may be going after the wrong therapeutic target altogether. My feeling was that if it was cheap, neurologists might prescribe it in a throw-everything-at-the-wall-and-see-what-sticks approach.

That said, we don't know a lot about Alzheimers, and there may be molecular subtypes of disease where the drug might work (my research background is in cancer and not neurological disease, so I'm not willing to speculate much here).

1
Reply
Share
Report
Save
Follow

I tend to be a buy and hold investor, but I will be looking at valuations closely this year and opportunities to rotate into higher moat value stocks. I look at specific names as much as sector. Corporate profits are still quite healthy, but valuations are very high and I’m anticipating a lackluster year for the market.

I think extraordinarily low interest rates pushed more investors into stocks to get any kind of yield, and with interest rates going up, there is pent up demand to return some of that money into lower risk investments. That will be a modest headwind.

T and BIIB have taken a beating. I think T is undervalued at this point. BIIB will be volatile until there’s more clarity on whether a market exists for its Alzheimer drug, but its price already reflects a negative outlook, so I think it has potential to pop on any positive developments. I think medical devices in particular are worth keeping an eye on. The revenue hit from the pause in elective medical procedures has largely been factored into prices there. If we get a break from Covid, there could be some good buys there.

Not in any way a financial analyst. I only play one on tv.

1
Reply
Share
Report
Save
Follow

New science paper says multiple sclerosis is caused by Epstein-Barr virus. A vaccine could prevent multiple sclerosis. https://www.science.org/doi/10.1126/science.abj8222

Calls on MRNA, short BIIB

1
Reply
Share
Report
Save
Follow

I am unemployed atm. Here are my options for tmr:

  1. Maybe i should stop playing with money?
  2. Continue pretending money is fake and keep punting (My deep out of money puts on tsla are still not giving me value) so keep on adding puts and get trapped once again
  3. YOLO -> Use a randomizer to pick names I want to long and short? (For tmr the randomizer says LONG PYPL, ABNB, ZM and SHORT BIIB, LCID, AAPL)

I quite like option 3

1
Reply
Share
Report
Save
Follow

Did anyone buy the BIIB dip yesterday

1
Reply
Share
Report
Save
Follow

BIOGEN (BIIB) went down a lot because their Alzheimer’s drug has been removed from Medicare’s approved medicines. It’s extremely undervalued at this point

1
Reply
Share
Report
Save
Follow

>*BIOGEN ENCOURAGES PATIENTS TO MAKE VOICES HEARD: CEO $BIIB

^*Walter ^Bloomberg ^@DeItaone ^at ^2022-01-13 ^08:12:31 ^EST-0500

1
Reply
Share
Report
Save
Follow

I agree with OP that the stock is undervalued and mispriced, with an asymmetric risk to upside.

There is a quote from Neil deGrasse Tyson that science doesn't care whether you believe it or not. SAVA doesn't require retails or anyone else to purchase the stock to set the share price. The stock is set by the value of a functioning Alzheimer treatment.

I look at the 2021-2022 $BIIB chart and see an extra $27B in Biogen market cap for their FDA-approved Alzheimer drug that was then taken away after it fizzled with Europe declining approval, low sales, its brain bleed side effects, and then the extra whammy last night of Medicare draft yesterday declining covering unless in a trial. So I rate that the value of a suboptimal Alzheimer drug from Biogen was $27B.

SAVA is around $2B now, and the initial data from phase 2 is their candidate drug has more impressive benefits than Biogen's, with no serious side effects. My SAVA target is thus conservative at $500, but I respect OP and others who have their own higher targets. SAVA is my favorite stock for this year, my largest individual stock holding, and I backed up the truck even more today.

The next few weeks I feel are going to be popcorn-worthy. Good luck to anyone in the play.

1
Reply
Share
Report
Save
Follow

I just put most of my money into $BIIB puts. I'll probably be in a Wendy's uniform also.

1
Reply
Share
Report
Save
Follow

The only stocks that fall under the description of "down 50% from their 52 week highs right now" are BIDU, BIIB, DOCU, MRNA, PDD, and PTON.

I'm not seeing anywhere near 40%.

1
Reply
Share
Report
Save
Follow

Buying BIIB weekly calls

1
Reply
Share
Report
Save
Follow

BIIB deserves to drop hard. That drug should have never been approved.

1
Reply
Share
Report
Save
Follow

Big news for Biogen: BIIB

https://www.washingtonpost.com/health/2022/01/11/alzheimers-drug-aduhelm-medicare-coverage

1
Reply
Share
Report
Save
Follow

Anyone know why $BIIB, Biogen, is down in AH?

1
Reply
Share
Report
Save
Follow

BIIB what you doin?

1
Reply
Share
Report
Save
Follow

Will Medicare cover Aduhelm?

I feel like buying some BIIB calls

1
Reply
Share
Report
Save
Follow

Will Medicare cover Aduhelm?

I feel like buying some BIIB calls

1
Reply
Share
Report
Save
Follow

I read the legal agreements, and my interpretation is they are obligated to pay the bonuses so long as after doing so they have 24 months of burn.

I don't agree with the LLY or BIIB approvals by the way.

There are sometimes phase 2 results that do show efficacy - but they are placebo controlled! The company made a choice to not do placebo phase 2 for cog data past 28 days, and instead did OLE. OLE is pretty good for getting more safety data, and yes, this drug appears safe.

But they couldve gotten a lot more placebo data for not a lot more money. Odd that they chose not to. I wonder why?

1
Reply
Share
Report
Save
Follow

The ADOS-Cog score is what matters! Not causing brain bleeding is a nice bonus compared to BIIB.

1
Reply
Share
Report
Save
Follow

BIIB.

1
Reply
Share
Report
Save
Follow

Yeah I agree, I’ve been looking at its competitors (BIIB) and they have the same price action but when it gaps up there is no rhyme or reason. It just trades sideways then boom back up 400%.

1
Reply
Share
Report
Save
Follow

What a douche bag. I have read the QMC report, and it's full of bullshit like you.

Don't you remember being a child?? Making mistakes, questioning your actions, unsure of yourself? She was a child who saw her family fall apart and temporarily recanted.

Further, her actions from decades ago are reasons to discredit her??? Is there any point in discussing chain of custody, CRAs, that those same sites ran trials for BIIB and LLY...?

I am not wasting any time. In fact, I hope you have a short position.

You shorts are amoral and morons.

1
Reply
Share
Report
Save
Follow
Recent Tweets
Biogen Inc's quarterly revenue growth rate YoY of -9.70% ranked 3475 out of 5766 companies in our database. https://t.co/Pr0WOnwzjc $BIIB 🚀🚀🚀🚀🚀 https://t.co/RIxFvJYAuB
0
0
0
$BIIB Trading Ideas | Awaiting Short signal. 100% Profitability based on 2 trades. Profit factor is 100. Learn more at https://t.co/uNaBDyBPlf. #BIIBSTOCK #stocks https://t.co/0RoVLTClKb
0
0
0
$BIIB Top analyst price target for next week>💸💰 https://t.co/Pg6R4oKjRL
0
0
0
$MRK $GILD $AMGN $BIIB... there are many biotech stocks acting well.... these four included... https://t.co/yQh9E9lHu2
9
10
89
Top and bottom-performers in terms of NBI growth contribution Momentum in CNS has been a key driver: (1) $BIIB Phase 3 lecanemab data (2) $NBIX Ingrezza sales and anticipated usage expansion (3) $KRTX Phase 3 schizophrenia treatment data (EMERGENT-2) https://t.co/hZ6SGIRvej
0
1
3
$BIIB Below Avg Volume Daily appearances since 2010: 162 Close 5 days later ±: Avg: -1.56 SD: 12.71 Worst: -80.31 Best: 63.66 10 days later: Avg: -2.32 SD: 16.80 Worst: -84.75 Best: 65.00 30 days later: Avg: 1.35 SD: 35.97 Worst: -88.61 Best: 147.11
0
0
0
Biogen upgraded to Buy at Argus on positive lecanemab data $BIIB
0
0
0
Unum Group price target raised to $48 from $43 at Truist $UNM $BIIB
0
0
0
Remember on 11/29, $BIIB will report P3 data on their Alzheimer drug candidate, BAN2401. This may drive other Alzheimer drug companies HIGHER!
0
0
0
I just saw a theory that $BIIB could be taken out within the next two years. But, seriously, who could both afford and want to buy Biogen?
1
0
4
$BIIB right now its riding the 4hr MA upwards with the 305.8 level hard support above it. Daily 8ma will reach it this week, and can push it above that level with next best res at 324.6. https://t.co/YN1bXoqCNd
0
2
7
In investing, the biggest gains are in companies that change the way we live, play or work. Finding a solution against Alzheimer’s and ALS certainly does change the way we live $AMLX $BIIB This is a must-watch space in the next decade. https://t.co/ZAt3YGIBgk
2
5
17
I love this untold story of lecanemab, Eisai and Biogen’s surprise victory in the mission to develop an Alzheimer’s treatment. BIogen’s stake in lecanemab, as it turns out, is the result of some executive arm-twisting and a $30 Jerry Garcia tie. https://t.co/Y0rzVrKZsD $BIIB
0
3
4
Roche’s experimental Alzheimer’s treatment fails to slow cognitive decline across two clinical trials https://t.co/B4gmyKh77J $RHHBY $ESALY $BIIB
6
12
29
Exclusive: Chris Viehbacher spoke to STAT's @matthewherper last night. Biogen’s new CEO, clear-eyed about company’s challenges, prepares to take the reins https://t.co/r2bfcsB1UO $BIIB
1
4
17
$AMGN $BIIB $GILD $LLY...I know folks are drooling over the oil and gas stocks...but, don't forget about the biotech/drug stocks...making new highs... https://t.co/K6ThZhxIPd
8
14
97
Biogen, $BIIB, has finalized a $900 million settlement resolving a whistleblower lawsuit accusing the biotech company of paying doctors kickbacks to prescribe multiple sclerosis drugs, the U.S. Department of Justice said.
29
76
308